Which route of growth hormone administration serves best? An invited commentary

被引：2

作者：

Strasburger, CJ ^{[1
]}

Kiess, W ^{[1
]}

机构：

[1] UNIV GIESSEN,DEPT GEN PAEDIAT & NEONATOL,CHILDRENS HOSP,GIESSEN,GERMANY

来源：

EUROPEAN JOURNAL OF ENDOCRINOLOGY | 1996年 / 135卷 / 03期

关键词：

D O I：

10.1530/eje.0.1350289

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：289 / 290

页数：2

共 7 条

[1] EPITHELIAL TRANSPORT AND BIOAVAILABILITY OF INTRANASALLY ADMINISTERED HUMAN GROWTH-HORMONE FORMULATED WITH THE ABSORPTION ENHANCERS DIDECANOYL-L-ALPHA-PHOSPHATIDYLCHOLINE AND ALPHA-CYCLODEXTRIN IN RABBITS [J].

AGERHOLM, C ;

BASTHOLM, L ;

JOHANSEN, PB ;

NIELSEN, MH ;

ELLING, F .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 83 (12) :1706-1711

[2] Review: Clinical Opportunities Provided by the Nasal Administration of Peptides [J].

Harris, A. S. .

JOURNAL OF DRUG TARGETING, 1993, 1 (02) :101-116

[3] INTRANASAL ADMINISTRATION OF HUMAN GROWTH-HORMONE (HGH) IN COMBINATION WITH A MEMBRANE PERMEATION ENHANCER IN PATIENTS WITH GH DEFICIENCY - A PHARMACOKINETIC STUDY [J].

HEDIN, L ;

OLSSON, B ;

DICZFALUSY, M ;

FLYG, C ;

PETERSSON, AS ;

ROSBERG, S ;

ALBERTSSONWIKLAND, K .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (04) :962-967

[4] PULSATILE VERSUS CONTINUOUS INTRAVENOUS ADMINISTRATION OF GROWTH-HORMONE (GH) IN GH-DEFICIENT PATIENTS - EFFECTS ON CIRCULATING INSULIN-LIKE GROWTH FACTOR-I AND METABOLIC INDEXES [J].

JORGENSEN, JOL ;

MOLLER, N ;

LAURITZEN, T ;

CHRISTIANSEN, JS .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (06) :1616-1623

[5] NASAL ABSORPTION OF GROWTH-HORMONE IN NORMAL SUBJECTS - STUDIES WITH 4 DIFFERENT FORMULATIONS [J].

LAURSEN, T ;

OVESEN, P ;

GRANDJEAN, B ;

JENSEN, S ;

JORGENSEN, JOL ;

ILLUM, P ;

CHRISTIANSEN, JS .

ANNALS OF PHARMACOTHERAPY, 1994, 28 (7-8) :845-848

[6]

LAURSEN T, 1994, ENDOCRINOL METAB, V1, P33

[7]

MULLER EE, 1989, ADV GROWTH HORMONE G

← 1 →